Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease von Fayek, S.A, Beshears, E, Lieber, R, Alvey, N, Sauer, A, Poirier, J, Hollinger, E.F, Olaitan, O.K, Jensik, S, Geyston, J, Brokhof, M.M, Hodowanec, A.C, Hertl, M, Simon, D.M

Volltext